| 1 |
33432521 | Co-delivery of doxorubicin and SIS3 by folate-targeted polymeric micelles for overcoming tumor multidrug resistance. | 2022 Jan |
1 |
| 2 |
35023460 | Inhibiting the Activity of ABCG2 by KU55933 in Colorectal Cancer. | 2022 Jan 12 |
1 |
| 3 |
35119449 | S-20, a steroidal saponin from the berries of black nightshade, exerts anti-multidrug resistance activity in K562/ADR cells through autophagic cell death and ERK activation. | 2022 Feb 21 |
1 |
| 4 |
32229058 | Isopetasin and S-isopetasin as novel P-glycoprotein inhibitors against multidrug-resistant cancer cells. | 2021 Jun |
1 |
| 5 |
33509236 | High expression of ABCG2 is associated with chemotherapy resistance of osteosarcoma. | 2021 Jan 28 |
1 |
| 6 |
33524223 | Doxorubicin-induced senescence promotes stemness and tumorigenicity in EpCAM-/CD133- nonstem cell population in hepatocellular carcinoma cell line, HuH-7. | 2021 Aug |
1 |
| 7 |
33602075 | A Combined Bioinformatic and Nanoparticle-Based Study Reveal the Role of ABCG2 in the Drug Resistant Breast Cancer. | 2021 |
3 |
| 8 |
33773562 | Curcumin Rescues Doxorubicin Responsiveness via Regulating Aurora a Signaling Network in Breast Cancer Cells. | 2021 Mar 1 |
1 |
| 9 |
33833512 | Nucleolin-Targeting AS1411 Aptamer-Modified Micelle for the Co-Delivery of Doxorubicin and miR-519c to Improve the Therapeutic Efficacy in Hepatocellular Carcinoma Treatment. | 2021 |
1 |
| 10 |
34031441 | The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells. | 2021 May 24 |
6 |
| 11 |
34094985 | AZ32 Reverses ABCG2-Mediated Multidrug Resistance in Colorectal Cancer. | 2021 |
2 |
| 12 |
34415509 | Lysophosphatidate Promotes Sphingosine 1-Phosphate Metabolism and Signaling: Implications for Breast Cancer and Doxorubicin Resistance. | 2021 Sep |
1 |
| 13 |
34679666 | The Cytotoxicity of Doxorubicin Can Be Accelerated by a Combination of Hyperthermia and 5-Aminolevulinic Acid. | 2021 Sep 27 |
1 |
| 14 |
31928387 | Modulation of ABCG2 surface expression by Rab5 and Rab21 to overcome multidrug resistance in cancer cells. | 2020 Aug |
1 |
| 15 |
32087276 | GPER mediates decreased chemosensitivity via regulation of ABCG2 expression and localization in tamoxifen-resistant breast cancer cells. | 2020 Apr 15 |
1 |
| 16 |
32712543 | The carotenoid fucoxanthin can sensitize multidrug resistant cancer cells to doxorubicin via induction of apoptosis, inhibition of multidrug resistance proteins and metabolic enzymes. | 2020 Oct |
1 |
| 17 |
33333736 | Elevated Production of Mitochondrial Reactive Oxygen Species via Hyperthermia Enhanced Cytotoxic Effect of Doxorubicin in Human Breast Cancer Cell Lines MDA-MB-453 and MCF-7. | 2020 Dec 15 |
9 |
| 18 |
31180052 | ABCG2 aptamer selectively delivers doxorubicin to drug-resistant breast cancer cells. | 2019 Jun |
2 |
| 19 |
29367724 | Elimination of stem-like cancer cell side-population by auranofin through modulation of ROS and glycolysis. | 2018 Jan 24 |
1 |
| 20 |
29458405 | Dacomitinib potentiates the efficacy of conventional chemotherapeutic agents via inhibiting the drug efflux function of ABCG2 in vitro and in vivo. | 2018 Feb 20 |
2 |
| 21 |
29551747 | Co-delivery of doxorubicin and imatinib by pH sensitive cleavable PEGylated nanoliposomes with folate-mediated targeting to overcome multidrug resistance. | 2018 May 5 |
1 |
| 22 |
29567542 | MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-κB signaling pathway in breast cancer. | 2018 Jun |
2 |
| 23 |
29568367 | The new allosteric inhibitor asciminib is susceptible to resistance mediated by ABCB1 and ABCG2 overexpression in vitro. | 2018 Mar 2 |
1 |
| 24 |
29649238 | Generation of multidrug resistant human tissues by overexpression of the ABCG2 multidrug transporter in embryonic stem cells. | 2018 |
1 |
| 25 |
30028120 | Overcoming Chemoresistance in Cancer via Combined MicroRNA Therapeutics with Anticancer Drugs Using Multifunctional Magnetic Core-Shell Nanoparticles. | 2018 Aug 15 |
1 |
| 26 |
30109181 | Olmutinib (HM61713) reversed multidrug resistance by inhibiting the activity of ATP-binding cassette subfamily G member 2 in vitro and in vivo. | 2018 Jul |
2 |
| 27 |
30114704 | PCI29732, a Bruton's Tyrosine Kinase Inhibitor, Enhanced the Efficacy of Conventional Chemotherapeutic Agents in ABCG2-Overexpressing Cancer Cells. | 2018 |
1 |
| 28 |
30120100 | Aspirin enhances the sensitivity of hepatocellular carcinoma side population cells to doxorubicin via miR-491/ABCG2. | 2018 Dec 21 |
6 |
| 29 |
30544754 | A Novel Synthetic Dihydroindeno[1,2-b] Indole Derivative (LS-2-3j) Reverses ABCB1- and ABCG2-Mediated Multidrug Resistance in Cancer Cells. | 2018 Dec 10 |
2 |
| 30 |
27816545 | Effect of abemaciclib (LY2835219) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo. | 2017 Jan 15 |
2 |
| 31 |
27911857 | YAP1 regulates ABCG2 and cancer cell side population in human lung cancer cells. | 2017 Jan 17 |
1 |
| 32 |
28106284 | Oxidative Stress Promotes Doxorubicin-Induced Pgp and BCRP Expression in Colon Cancer Cells Under Hypoxic Conditions. | 2017 Jul |
3 |
| 33 |
28214549 | ATP-dependent activity and mitochondrial localization of drug efflux pumps in doxorubicin-resistant breast cancer cells. | 2017 May |
4 |
| 34 |
28303028 | Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo. | 2017 Mar 17 |
3 |
| 35 |
28455266 | Suppression of ABCG2 mediated MDR in vitro and in vivo by a novel inhibitor of ABCG2 drug transport. | 2017 Jul |
1 |
| 36 |
28750689 | Peri-foci adipose-derived stem cells promote chemoresistance in breast cancer. | 2017 Jul 27 |
2 |
| 37 |
28825695 | Augmenter of liver regeneration potentiates doxorubicin anticancer efficacy by reducing the expression of ABCB1 and ABCG2 in hepatocellular carcinoma. | 2017 Dec |
2 |
| 38 |
28935760 | Ultrasound reverses chemoresistance in breast cancer stem cell like cells by altering ABCG2 expression. | 2017 Dec 22 |
1 |
| 39 |
28964574 | Epigallocatechin-3-gallate promotes apoptosis and reversal of multidrug resistance in esophageal cancer cells. | 2017 Oct |
3 |
| 40 |
29039601 | Vasohibin2 promotes adriamycin resistance of breast cancer cells through regulating ABCG2 via AKT signaling pathway. | 2017 Dec |
1 |
| 41 |
26330294 | Isocyclopamine, a novel synthetic derivative of cyclopamine, reverts doxorubicin resistance in MCF-7/ADR cells by increasing intracellular doxorubicin accumulation and downregulating breast cancer stem-like cells. | 2016 Feb |
1 |
| 42 |
26862532 | Simultaneous Analysis of Wnt and NF-κB Signaling Pathways in Doxorubicin Sensitive and Methotrexate Resistant PLC/ PRF/5 Cells. | 2016 Winter |
1 |
| 43 |
27033456 | The phytoestrogen genistein enhances multidrug resistance in breast cancer cell lines by translational regulation of ABC transporters. | 2016 Jun 28 |
1 |
| 44 |
27160689 | Gibberellin derivative GA-13315 sensitizes multidrug-resistant cancer cells by antagonizing ABCB1 while agonizes ABCC1. | 2016 Jul |
1 |
| 45 |
27196753 | Osimertinib (AZD9291) Enhanced the Efficacy of Chemotherapeutic Agents in ABCB1- and ABCG2-Overexpressing Cells In Vitro, In Vivo, and Ex Vivo. | 2016 Aug |
2 |
| 46 |
27247490 | Silencing of ABCG2 by MicroRNA-3163 Inhibits Multidrug Resistance in Retinoblastoma Cancer Stem Cells. | 2016 Jun |
1 |
| 47 |
27348602 | Enhanced Sensitivity of Cancer Stem Cells to Chemotherapy Using Functionalized Mesoporous Silica Nanoparticles. | 2016 Aug 1 |
2 |
| 48 |
27684197 | Improving the Intracellular Drug Concentration in Lung Cancer Treatment through the Codelivery of Doxorubicin and miR-519c Mediated by Porous PLGA Microparticle. | 2016 Nov 7 |
1 |
| 49 |
25459885 | Activity of the dietary flavonoid, apigenin, against multidrug-resistant tumor cells as determined by pharmacogenomics and molecular docking. | 2015 Jan |
1 |
| 50 |
25534417 | The c-MET/PI3K signaling is associated with cancer resistance to doxorubicin and photodynamic therapy by elevating BCRP/ABCG2 expression. | 2015 |
6 |